Phase 3 Readouts Current
A Trials medical research trial page covering what it tests, design & endpoints, who is enrolled and results so far, alongside the 7 reports filed on it so
Natera partners with Angiex on cancer trial
Natera has partnered with Angiex to evaluate its Signatera blood test in a phase 1 trial of the cancer drug AGX101.
AstraZeneca, Amgen's Tezspire succeeds in
AstraZeneca and Amgen's Tezspire succeeded in a Phase 3 trial for eosinophilic esophagitis, potentially expanding the label for the immunology drug.
AusperBio raises $120M for hepatitis B trial
AusperBio Therapeutics raised $120 million in a series C round led by RA Capital to advance its hepatitis B drug candidate AHB-137 into phase 3...
Akeso’s Biliary Tract Win Shows ivonescimab Beyond Lung Cancer
Akeso’s CEO highlights a phase-3 success in biliary tract cancer while defending the drug’s data amid NSCLC concerns.
TALENTOP trial: conversion surgery in advanced HCC
The TALENTOP study, a multicentre, open-label, randomised phase 3 trial, compares liver resection after atezolizumab and bevacizumab with maintenance...
Moderna-Merck Cancer Vaccine
Moderna and Merck's individualized cancer vaccine shows promise in Phase 3 trial for melanoma
Eyepoint Study Results Disappoint for Vision Treatment
Eyepoint's experimental treatment for age-related blindness fails to meet primary goal in Phase 3 clinical trial.